Tomoyuki Katsuzaki

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.

Toshimitsu Niwa, Tomoyuki Katsuzaki, Shigeru Miyazaki et al. · Journal of Clinical Investigation · 1997 · 192 citations · Full text

Glycation End Product, Glycobiology, Immunology +18

Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum

Toshimitsu Niwa, Tomoyuki Katsuzaki, Tomoko Momoi et al. · Kidney International · 1996 · 80 citations · Full text

3-Dg Accumulating, Biochemistry, Medicine +7

Amyloid β2-microglobulin is modified with Nε-(carboxymethyl)lysine in dialysis-related amyloidosis

Toshimitsu Niwa, Mitsuhiko Sato, Tomoyuki Katsuzaki et al. · Kidney International · 1996 · 66 citations

Biochemistry, Medicine, Natural Sciences +8

Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: Role of the polyol pathway

Saori Tsukushi, Tomoyuki Katsuzaki, Isao Aoyama et al. · Kidney International · 1999 · 63 citations

Hemodialysis, Urology, Renal Function +12

Amyloid β2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis

Toshimitsu Niwa, Tomoyuki Katsuzaki, Shigeru Miyazaki et al. · Kidney International · 1997 · 61 citations

Glycation End Product, Engineering, Biochemistry +9